Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 22 Feb 2017
At a glance
- Drugs Follitropin alfa (Primary)
- Indications Infertility
- Focus Registrational; Therapeutic Use
- Acronyms FIN3002
- Sponsors FINOX
- 10 Feb 2016 Planned number of patients changed from 1106 to 1100 as reported by ClinicalTrials.gov.
- 10 Feb 2016 Planned End Date changed from 1 Mar 2016 to 1 Apr 2017 as reported by ClinicalTrials.gov.
- 10 Feb 2016 Planned primary completion date changed from 1 Jun 2015 to 1 Apr 2016 as reported by ClinicalTrials.gov.